Profile data is unavailable for this security.
About the company
Qyuns Therapeutics Co Ltd is a China-based company mainly engaged in biopharmaceuticals. The Company is mainly engaged in biotechnology research and development of biological therapies for autoimmune and allergic diseases. The Company's business mainly covers four major disease areas, including skin, rheumatism, respiratory and digestive tract diseases. The Company is developing eight projects, with target indications including psoriasis, atopic dermatitis, rheumatoid arthritis, inflammatory bowel disease and asthma. The Company's core products include QX002N and QX005N.
- Revenue in HKD (TTM)48.88m
- Net income in HKD-458.98m
- Incorporated2015
- Employees325.00
- LocationQyuns Therapeutics Co LtdRoom 1310Building 1, No. 907 Yaocheng AvenueTAIZHOU ChinaCHN
- Phone+86 52 380276311
- Websitehttp://www.qyuns.net/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mabpharm Ltd | 164.99m | -225.16m | 1.44bn | 297.00 | -- | 11.52 | -- | 8.75 | -0.0546 | -0.0546 | 0.04 | 0.0304 | 0.164 | 0.1937 | 3.26 | 475,468.60 | -22.38 | -21.42 | -31.11 | -27.49 | 86.91 | -- | -136.47 | -486.40 | 0.6836 | -22.44 | 0.679 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| Hua Medicine | 118.54m | -286.59m | 1.90bn | 172.00 | -- | -- | -- | 16.03 | -0.2923 | -0.2923 | 0.1209 | -0.0368 | 0.0779 | 1.51 | 3.31 | 669,738.80 | -18.84 | -25.61 | -23.63 | -28.81 | 37.72 | -- | -241.76 | -1,654.70 | 4.64 | -- | 1.14 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
| Frontage Holdings Corp | 2.02bn | 47.39m | 1.97bn | 1.66k | 42.32 | 0.755 | 5.85 | 0.9775 | 0.0229 | 0.0229 | 0.9864 | 1.28 | 0.4701 | 56.23 | 4.58 | 1,148,467.00 | 1.06 | 4.46 | 1.30 | 5.28 | 28.56 | 34.00 | 2.26 | 9.92 | 1.25 | 2.37 | 0.311 | 0.00 | 3.79 | 25.61 | -58.00 | -0.7826 | 40.43 | -- |
| Biocytogen Pharmaceuticals Beijng Co Ltd | 871.13m | -265.31m | 2.40bn | 1.04k | -- | 2.98 | -- | 2.76 | -0.6662 | -0.6662 | 2.19 | 2.02 | 0.3109 | 23.64 | 5.36 | 817,199.70 | -9.47 | -- | -12.44 | -- | 71.97 | -- | -30.46 | -- | 1.33 | -4.18 | 0.436 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| CStone Pharmaceuticals | 496.77m | -154.85m | 2.52bn | 164.00 | -- | 4.95 | -- | 5.07 | -0.1215 | -0.1215 | 0.3896 | 0.3963 | 0.2861 | 1.33 | 2.50 | 2,159,871.00 | -8.92 | -54.76 | -16.99 | -81.68 | 70.73 | -- | -31.17 | -301.62 | 1.45 | -- | 0.4171 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 410.23k | -407.39m | 2.79bn | 150.00 | -- | 4.27 | -- | 6,794.95 | -1.13 | -1.13 | 0.0011 | 1.75 | -- | -- | -- | 2,829.16 | -- | -- | -- | -- | -- | -- | -99,307.43 | -- | -- | -- | 0.14 | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| Qyuns Therapeutics Co Ltd | 48.88m | -458.98m | 2.80bn | 325.00 | -- | 7.00 | -- | 57.25 | -1.96 | -1.96 | 0.2219 | 1.80 | -- | -- | -- | 147,667.70 | -- | -- | -- | -- | 84.05 | -- | -976.77 | -- | 1.83 | -29.56 | 0.5795 | -- | -- | -- | -70.28 | -- | -- | -- |
| Abbisko Cayman Ltd | 541.10m | -17.63m | 3.34bn | 275.00 | -- | 1.48 | 929.47 | 6.18 | -0.0299 | -0.0299 | 0.8332 | 3.32 | 0.2159 | -- | 65.75 | 2,097,290.00 | -0.7034 | -- | -0.733 | -- | 0.00 | -- | -3.26 | -- | -- | -- | 0.0142 | -- | -- | -- | 12.92 | -- | -- | -- |
| Alphamab Oncology | 278.42m | -234.63m | 3.98bn | 429.00 | -- | 2.25 | -- | 14.28 | -0.2437 | -0.2437 | 0.2892 | 1.84 | 0.1145 | 0.8256 | 13.94 | 640,049.40 | -9.65 | -18.72 | -11.16 | -21.94 | 79.33 | -- | -84.27 | -415.55 | 4.42 | -- | 0.167 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
| Laekna Inc | 0.00 | -321.58m | 4.17bn | 92.00 | -- | 5.67 | -- | -- | -0.9024 | -0.9024 | 0.00 | 1.89 | 0.00 | -- | -- | 0.00 | -31.46 | -- | -35.71 | -- | -- | -- | -- | -- | -- | -- | 0.0856 | -- | -- | -- | 52.81 | -- | -- | -- |
Data as of Nov 08 2024. Currency figures normalised to Qyuns Therapeutics Co Ltd's reporting currency: Hong Kong Dollar HKD
